Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia

✍ Scribed by Ellin Berman; Peter Wiernik; Ralph Vogler; Enrique Vélez-Gárcia; Alfred Bartolucci; Fredrick S. Whaley

• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 151 KB
• Volume: 80
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/(sici)1097-0142(19971201)80:11+<2181::aid-cncr3>3.0.co;2-l

✦ Synopsis

BACKGROUND. Most clinical trials for acute leukemia have reported results after